Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
Holding IPHYF?
Track your performance easily
IPHYF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.25 - $3.22
Previous CloseN/A
Volume10.00
Average Volume (3M)56.00
Market Cap
$150.36M
Enterprise Value$95.26M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Mar 27, 2025EPS Estimate
-0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding83,830,340
10 Day Avg. Volume0
30 Day Avg. Volume56
Standard Deviation0.26
R-Squared0.02
Alpha0.00488
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.55
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.24Price Target Upside11.72% Upside
Rating ConsensusHold
Number of Analyst Covering1
Innate Pharma SA News
PremiumCompany Announcements
Innate Pharma Begins Phase 1 Study of New Cancer Therapy
PremiumCompany Announcements
Innate Pharma to Showcase ADC Innovations at Upcoming New York Event
PremiumCompany Announcements
Innate Pharma Reports Share and Voting Rights Update
PremiumCompany Announcements
Innate Pharma Unveils Growth Strategy Focused on Innovation and Partnerships
PremiumCompany Announcements
Innate Pharma to Present at J.P. Morgan Healthcare Conference
Ownership Overview
―
Insiders
0.03% Other Institutional Investors
99.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IPHYF FAQ
What was Innate Pharma SA’s price range in the past 12 months?
Innate Pharma SA lowest stock price was $1.25 and its highest was $3.22 in the past 12 months.
What is Innate Pharma SA’s market cap?
Innate Pharma SA’s market cap is $150.36M.
When is Innate Pharma SA’s upcoming earnings report date?
Innate Pharma SA’s upcoming earnings report date is Mar 27, 2025 which is in 56 days.
How were Innate Pharma SA’s earnings last quarter?
Innate Pharma SA released its earnings results on Sep 12, 2024. The company reported -$0.323 earnings per share for the quarter, missing the consensus estimate of -$0.291 by -$0.031.
Is Innate Pharma SA overvalued?
According to Wall Street analysts Innate Pharma SA’s price is currently Undervalued.
Does Innate Pharma SA pay dividends?
Innate Pharma SA does not currently pay dividends.
What is Innate Pharma SA’s EPS estimate?
Innate Pharma SA’s EPS estimate is -0.27.
How many shares outstanding does Innate Pharma SA have?
Innate Pharma SA has 83,830,340 shares outstanding.
What happened to Innate Pharma SA’s price movement after its last earnings report?
Innate Pharma SA reported an EPS of -$0.323 in its last earnings report, missing expectations of -$0.291. Following the earnings report the stock price went down -3.333%.
Which hedge fund is a major shareholder of Innate Pharma SA?
Currently, no hedge funds are holding shares in IPHYF
---
Company Description
Innate Pharma SA
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
---
IPHYF Company Deck
---
IPHYF Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---